Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic impact of ARHGAP43(SH3BP1) in acute myeloid leukemia.

Journal of the Formosan Medical Association = Taiwan yi zhi - 1 Sept 2024

Yang Li, Xu Qiang, Li Junnan

Abstract excerpt

BACKGROUND: Acute myeloid leukemia (AML) is a hematological malignancy with a heterogeneous prognosis. Novel markers are required to accurately assess the prognosis and formulate treatment plans. METHODS: The association of ARHGAP family genes with prognostic value in acute myeloid leukemia (AML) was assessed using public databases (CCLE, GEPIA, TCGA, and GEO). RESULTS: Elevated expression of ARHGAP43 (SH3BP1)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Cell Line, Tumor
Share to GTPase-Activating Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hematopoietic Stem Cell Transplantation

Share to Leukemia, Myeloid, Acute

Share to Prognosis

Share to Progression-Free Survival

Share to Proportional Hazards Models

Source

Identifiers

PMID: 38582737
DOI: 10.1016/j.jfma.2024.04.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic impact of ARHGAP43(SH3BP1) in acute myeloid leukemia.PMID 38582737Read ↗

SASH3 is an unfavorable prognostic immune biomarker in patients with acute myeloid leukemia(AML).Semantic proximity Read ↗

High Expression of AHSP, EPB42, GYPC and HEMGN Predicts Favorable Prognosis in FLT3-ITD-Negative Acute Myeloid Leukemia.Semantic proximity Read ↗

Comprehensive analysis of SPAG1 expression as a prognostic and predictive biomarker in acute myeloid leukemia by integrative bioinformatics and clinical validation.Semantic proximity Read ↗

The Role of ARHGAP9: Clinical Implication and Potential Function in Acute Myeloid LeukemiaSemantic proximity Read ↗

GATA2 rs2335052 and GATA2 rs78245253 single-nucleotide polymorphisms in Chinese patients with acute myelocytic leukemia.Semantic proximity Read ↗

DDX43 promoter is frequently hypomethylated and may predict a favorable outcome in acute myeloid leukemia.Semantic proximity Read ↗

Favorable prognosis of biallelic CEBPA gene mutations in acute myeloid leukemia patients: a meta-analysis.Semantic proximity Read ↗

Signal transducer and activator of transcription 3 (STAT3) gene polymorphisms are associated with treatment outcomes in acute myeloid leukemia.Semantic proximity Read ↗

Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemia.Semantic proximity Read ↗

Identification of Prognostic Biomarker and Immune Infiltration of CDH23 in Acute Myeloid LeukemiaSemantic proximity Read ↗

LncRNA CD27-AS1 promotes acute myeloid leukemia progression through the miR-224-5p/PBX3 signaling circuitSemantic proximity Read ↗

Integrated Analysis and Validation Reveal CYTH4 as a Potential Prognostic Biomarker in Acute Myeloid LeukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.